Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Pharmacologic Treatment of Downstream of Tyrosine Kinase 7 Congenital Myasthenic Syndrome
Nanna Witting,
John Vissing
Department of Clinical Medicine
18
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacologic Treatment of Downstream of Tyrosine Kinase 7 Congenital Myasthenic Syndrome'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Congenital Myasthenic Syndromes
100%
Protein-Tyrosine Kinases
57%
Ephedrine
28%
Albuterol
25%
Cholinesterase Inhibitors
24%
2,4-diaminopyridine
15%
Amifampridine
11%
Therapeutics
10%
Muscle Fatigue
8%
Myasthenia Gravis
8%
Muscle Weakness
7%
Drug Combinations
7%
Age of Onset
6%
Publications
5%
PubMed
5%
Databases
4%
Mutation
3%
Pharmaceutical Preparations
2%